Kenneth T. Mills
Chairman
REGENXBIO Inc. (RGNX)Equibles does not estimate personal net worth.
Get an email with a short summary when REGENXBIO Inc. publishes a filing, an earnings call transcript or a press release.
Get RGNX alertsAbout Kenneth T. Mills
Kenneth T. Mills is recorded as Chairman at REGENXBIO Inc. (RGNX) since June 13, 2024. REGENXBIO Inc. reported in an 8-K filed October 16, 2026 that Kenneth T. Mills resigned as board of directors, effective October 21, 2026. The same filing states: “Mr. Mills’ decision was not related to any disagreement with the Company on any matter relating to its operations, policies, or practices.” REGENXBIO Inc. reported in an 8-K filed June 13, 2024 that Kenneth T. Mills was appointed Chairman of the Board. The proxy statement of REGENXBIO Inc. reports total compensation of $5,507,038 for Kenneth T. Mills in fiscal 2024, including a base salary of $340,998. Disclosed compensation is on record for 7 fiscal years. REGENXBIO Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at REGENXBIO Inc. includes Curran M. Simpson (CEO, COO and Board Member), Allan M. Fox (Chairman and Board Member), George Migausky (Chairman and Board Member) and 7 others.
“On October 14, 2026, Kenneth T. Mills resigned from the board of directors (the "Board") of REGENXBIO Inc. (the "Company") effective October 21, 2026.”
“Mr. Mills’ decision was not related to any disagreement with the Company on any matter relating to its operations, policies, or practices.”
“Mr. Mills will continue to serve as a director and has been named Chairman of the Board.”
Affiliation history
-
Current
2024-06-13–present
-
2009-01-01–2026-10-21
Company network
Leadership on record at REGENXBIO Inc.
- Curran M. Simpson CEO, COO, Board Member
- Allan M. Fox Chairman, Board Member
- George Migausky Chairman, Board Member
- Mitchell Chan Chief Accounting Officer
- Alexandra Glucksmann Board Member
- Alexandra Glucksmann, Ph.D. Board Member
- Curran Simpson Board Member
- Daniel Tassé Board Member
- David Stump Board Member
- George V. Migausky Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | REGENXBIO Inc. (RGNX) | Former President and CEO | $340,998 | $5,507,038 |
| 2023 | REGENXBIO Inc. (RGNX) | Former President and CEO | $676,790 | $5,916,713 |
| 2022 | REGENXBIO Inc. (RGNX) | Former President and CEO | $650,759 | $5,753,713 |
| 2021 | REGENXBIO Inc. (RGNX) | President and CEO | $631,805 | $8,622,941 |
| 2020 | REGENXBIO Inc. (RGNX) | President and CEO | $613,403 | $7,644,087 |
| 2019 | REGENXBIO Inc. (RGNX) | President and CEO | $595,537 | $6,147,269 |
| 2018 | REGENXBIO Inc. (RGNX) | President and CEO | $546,364 | $4,938,199 |
Recent activity
-
Executive change Resigned: board of directors
“Mr. Mills’ decision was not related to any disagreement with the Company on any matter relating to its operations, policies, or practices.”
REGENXBIO Inc. (RGNX) -